Efficacy of Tocilizumab for Treatment of Severe COVID-19 Pneumonia: More Evidence Is Needed

Bruno De Oliveira; Jihad Mallat

doi:10.1093/cid/ciaa1284

Efficacy of Tocilizumab for Treatment of Severe COVID-19 Pneumonia: More Evidence Is Needed

Cleveland Clinic Abu Dhabi

Normandy University

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	E271-E272
Journal	Clinical Infectious Diseases
Volume	73
Issue number	1
DOIs	https://doi.org/10.1093/cid/ciaa1284
State	Published - 1 Jul 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1093/cid/ciaa1284

Cite this

@article{7db9da8f527a46419485a95214e9b6fb,

title = "Efficacy of Tocilizumab for Treatment of Severe COVID-19 Pneumonia: More Evidence Is Needed",

author = "\{De Oliveira\}, Bruno and Jihad Mallat",

year = "2021",

month = jul,

day = "1",

doi = "10.1093/cid/ciaa1284",

language = "English",

volume = "73",

pages = "E271--E272",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Efficacy of Tocilizumab for Treatment of Severe COVID-19 Pneumonia

T2 - More Evidence Is Needed

AU - De Oliveira, Bruno

AU - Mallat, Jihad

PY - 2021/7/1

Y1 - 2021/7/1

UR - https://www.scopus.com/pages/publications/85111789475

U2 - 10.1093/cid/ciaa1284

DO - 10.1093/cid/ciaa1284

M3 - Letter

C2 - 32886762

AN - SCOPUS:85111789475

SN - 1058-4838

VL - 73

SP - E271-E272

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 1

ER -

Efficacy of Tocilizumab for Treatment of Severe COVID-19 Pneumonia: More Evidence Is Needed

UN SDGs

Access to Document

Other files and links

Cite this